Risk factors and clinical outcomes of penicillin-resistant S. pneumoniae community-acquired pneumonia in Khon Kaen, Thailand

Southeast Asian Journal of Tropical Medicine and Public Health

Volumn 37, Issue 2, 2006, Pages 320-326

  Reechaipichitkul, Wipa ^a   Assawasanti, Kanogsri ^a   Chaimanee, Prajuap ^a  

^a KHON KAEN UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33746031377     PISSN: 01251562     EISSN: 26975718     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Aspa J, Rajas O, de Castro FR, et al. Drug-resistant pneumococcal pneumonia: clinical relevance and related factors. Clin Infect Dis 2004; 38: 787-98.
2. Clavo-Sanchez AJ, Giron-Gonzalez JA, Lopez-Prieto D, et al. Multivariate analysis of risk factors for infection due to penicillin-resistant and multidrug-resistant Streptococcus pneumoniae: a multicenter study. Clin Infect Dis 1997; 24: 1052-9.
3. Cunha BA. Clinical relevance of penicillin-resistant Streptococcus pneumoniae. Semin Respir Infect 2002; 17: 204-14.
4. Dejthevaporn C, Vibhagool A, Thakkinstian A, et al. Risk factors for penicillin-resistant Streptococcus pneumoniae acquisition in patients in Bangkok. Southeast Asian J Trop Med Public Health 2000; 31: 679-83.
5. Falco V, Almirante B, Jordano Q, et al. Influence of penicillin resistance on outcome in adult patients with invasive pneumococcal: is penicillin useful against intermediately resistant strain? J Antimicrob Chemother 2004; 54: 481-8.
6. Feikin DR, Schuchat A, Kolczak M, et al. Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance; 1995-1997. Am J Public Health 2000; 90: 223-9.
7. Feldman C. Clinical relevance of antimicrobial resistance in the management of pneumococcal community-acquired pneumonia. J Lab Clin Med 2004; 143: 269-83.
8. File TM Jr. Community-acquired pneumonia. Lancet 2003; 362: 1991-2001.
9. File TM Jr. Streptococcus pneumoniae, and community-acquired pneumonia: a cause of concern. Am J Med 2004; 117 (suppl 3A): 39S-50S.
10. Garau J. Treatment of drug-resistant pneumococcal pneumonia. Lancet Infect Dis 2002; 2: 404-15.
11. Heffelfinger JD, Dowell SF, Jorgensen JH, et al. Management of community-acquired pneumonia in the era of pneumococcal resistance: a report from the drug-resistant Streptococcus pneumoniae therapeutic working group. Arch Intern Med 2000; 160: 1399-408.
12. Ho PL, Yung RWH, Tsang DNC, et al. Increasing resistance of Streptococcus pneumoniae to fluoroquinolones: results of Hong Kong multicentre study in 2000. J Antimicrob Chemother 2001; 48: 659-65.
13. Jacobs MR. Drug-resistant Streptococcus pneumoniae: rational antibiotic choices. Am J Med 1999; 106 (suppl 1A): 19S-25S.
14. Klugman K, Koornhof H, Friedland I. Antibiotic resistance in pneumococcal meningitis. Lancet 1992; 340: 437-8.
15. Mandell LA, Bartlett JG, Dowell SF, et al. Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adult: IDSA guidelines. Clin Infect Dis 2003; 37: 1405-33.
16. Metlay JP, Hofmann J, Cetron MS, et al. Impact of penicillin susceptibility on medical outcomes for adult patients with bacteremic pneumococcal pneumonia. Clin Infect Dis 2000; 30: 520-8.
17. Musher DM, Montoya R, Wanahita A. Diagnostic value of microscopic examination of Gram-stained sputum and sputum cultures in patients with bacteremic pneumococcal pneumonia. Clin Infect Dis 2004; 39: 165-9.
18. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility test: Sixth Information (suppl) Villanova, PA; NCCLS, 1997 (NCCLS document M2-M6).
19. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing: Twelve Information (suppl) Wayne PA; NCCLS, 2002 (NCCLS document M100-S12).
20. Niederman MS, Mandell LA, Anzueto A, et al. Guidelines for the management of adults with community-acquired pneumonia: diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med 2001; 163: 1730-54.
21. Nuermberger EL, Bishai WR. Antibiotic resistance in Streptococcus pneumoniae: what does the future hold? Clin Infect Dis 2004; 38 (suppl 4): 363S-371S.
22. Sangthawan P, Chantaratchada S, Chanthadisai N, Wattanathum A. Prevalence and clinical significance of community-acquired penicillin-resistant pneumococcal pneumonia in Thailand. Respirology 2003; 8: 208-12.
23. Song JH, Jung SI, Ko KS, et al. High prevalence of antimicrobial resistance among clinical Streptococcus pneumoniae isolates in Asia (an ANSORP study). Antimicrob Agents Chemother 2004; 48: 2101-7.
24. Yanagihara K, Otsu Y, Ohno H, et al. Clinical characteristics of pneumonia caused by penicillin resistant and sensitive Streptococcus pneumoniae in Japan. Intern Med 2004; 43: 1029-33.
25. Zhanel GG, Ennis K, Vercaigne L, et al. A critical review of the fluoroquinolones: focus on respiratory infections. Drugs 2002; 62: 13-59.